Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Novo Nordisk (NVO) posts Q3 sales for its weight loss drug Wegovy, contrasting rival Eli Lilly's (LLY) quarterly miss for its obesity drug, Zepbound. Read more here.

Eli Lilly’s (NYSE: LLY) market isn’t out of the weeds yet but will rebound strongly in 2025. The Q3 results failed to spark a ...

Jim Cramer, the host of Mad Money, recently delved into the complexities of disappointing quarterly earnings, emphasizing the importance of transparent communication from management. He pointed out ...

A wealthy tech boss is under fire over his unusual side-hustle - peddling puppies that animal welfare groups say are bred in cruel, factory-like conditions.

Even with this partial rebound, Lilly's share price remains roughly 13% below the peak set in late August. Some investors ...